标题
When GLP-1 hits the liver: a novel approach for insulin resistance and NASH
作者
关键词
-
出版物
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Volume 302, Issue 8, Pages G759-G761
出版商
American Physiological Society
发表日期
2012-03-04
DOI
10.1152/ajpgi.00078.2012
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition
- (2011) Michael Charlton et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Nonalcoholic steatohepatitis
- (2011) Jörn M. Schattenberg et al. CURRENT OPINION IN LIPIDOLOGY
- Current therapeutic strategies in non-alcoholic fatty liver disease
- (2011) J. K. Dowman et al. DIABETES OBESITY & METABOLISM
- A High-Cholesterol Diet Exacerbates Liver Fibrosis in Mice via Accumulation of Free Cholesterol in Hepatic Stellate Cells
- (2011) Toshiaki Teratani et al. GASTROENTEROLOGY
- Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice
- (2011) Savitha Subramanian et al. JOURNAL OF LIPID RESEARCH
- Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis
- (2011) Gianluca Svegliati-Baroni et al. LIVER INTERNATIONAL
- GLP-1 Analogs Reduce Hepatocyte Steatosis and Improve Survival by Enhancing the Unfolded Protein Response and Promoting Macroautophagy
- (2011) Shvetank Sharma et al. PLoS One
- Rapid quantification of myocardial fibrosis: a new macro-based automated analysis
- (2011) Awal M. Hadi et al. CELLULAR ONCOLOGY
- The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats
- (2010) Que Liu et al. Cardiovascular Diabetology
- Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway
- (2010) Nitika Arora Gupta et al. HEPATOLOGY
- Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis
- (2010) Wing-Kin Syn et al. HEPATOLOGY
- Leptin Promotes the Myofibroblastic Phenotype in Hepatic Stellate Cells by Activating the Hedgehog Pathway
- (2010) Steve S. Choi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis
- (2010) Lisa Lo et al. JOURNAL OF HEPATOLOGY
- The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis
- (2010) Detlef Schuppan et al. LIVER INTERNATIONAL
- Targeting liver fibrosis: Strategies for development and validation of antifibrotic therapies
- (2009) Yury Popov et al. HEPATOLOGY
- Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
- (2009) E. Fabbrini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent
- (2008) Laura H. Tetri et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Inhibition of Integrin αvβ6 on Cholangiocytes Blocks Transforming Growth Factor-β Activation and Retards Biliary Fibrosis Progression
- (2008) Eleonora Patsenker et al. GASTROENTEROLOGY
- Competitive inhibition of leptin signaling results in amelioration of liver fibrosis through modulation of stellate cell function
- (2008) Eran Elinav et al. HEPATOLOGY
- Integrin αvβ6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies
- (2008) Yury Popov et al. JOURNAL OF HEPATOLOGY
- Liver cirrhosis
- (2008) Detlef Schuppan et al. LANCET
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started